o-Tolyloxy-aceton | 13662-01-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: o-Tolyloxy-aceton
• 英文别名: 2-Methylphenoxy-aceton；o-tolyloxy-acetone；o-Tolyl-acetonyl-aether；o-Kresoxyaceton；Acetol-o-tolylaether；(2-Methyl-phenoxy)-propone；1-(2-methylphenoxy)propan-2-one
• CAS: 13662-01-6
• 化学式: C₁₀H₁₂O₂
• mdl: MFCD12145604
• 分子量: 164.204
• InChiKey: RTRHQNMVGFFMGE-UHFFFAOYSA-N

物化性质

• 熔点：
  240-241 °C
• 沸点：
  246.5±15.0 °C(Predicted)
• 密度：
  1.027±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  o-Tolyloxy-aceton 在 硫酸 作用下， 生成 3,7-二甲基苯并呋喃
  参考文献：
  名称：

  Stoermer, Justus Liebigs Annalen der Chemie, 1900, vol. 312, p. 289

  摘要：

  DOI：
• 作为产物：
  描述：

  邻甲酚 生成 o-Tolyloxy-aceton
  参考文献：
  名称：

  LE CORRE M.; HERCOUEET A.; BEGASSE B.; RUEGER W., ACTES 1-ER CONGR. INT. COMPOS. PHOSPHORES, RABAT, 1977, PARIS, 607-610

  摘要：

  DOI：

文献信息

• HIV protease inhibiting compounds
  申请人：Randolph T. John

  公开号：US20050159469A1

  公开（公告）日：2005-07-21

  A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

  公开了一种公式的化合物作为HIV蛋白酶抑制剂。还公开了用于抑制HIV感染的方法和组合物。
• Process for manufacture of aryloxy-alkylamino butanones
  申请人：GEIGY AG J R

  公开号：US02344814A1

  公开（公告）日：1944-03-21

  552,454. Aryloxy-alkylamino butanones. GEIGY AKT.-GES., J. R. Oct. 7, 1941, No. 12937. Convention date, Oct. 8, 1940. [Class 2 (iii)] Aryloxy-alkylamino butanones are prepared by first condensing a monovalent phenol or a derivative of a polyvalent phenol containing only one hydroxyl group with a monohalogen acetone and then treating the aryloxy acetone so produced with a hydroxymethylamine, In place of the hydroxymethylamine there may be employed the reaction mixture obtained from formaldehyde and a primary or a secondary amine. The butanones thus obtained may be reduced to the corresponding butanols. In examples (1) Monochloracetone is condensed with o-cresol in the presence of sodium hydroxide and the o-cresoxyacetone so produced treated with the crude condensation product obtained by reacting piperidine with formaldehyde. The resulting o-cresoxybutanonyl-piperidine 1- (2<;SP>;1<;/SP>; - methylphenoxy - 1') - 4 - piperidyl - butanone-2 is purified by distillation. (2) A benzene solution of o-cresoxyacetone is treated with diethylamine to give 1-(2<;SP>;1<;/SP>;-methyl-phenoxy- 1<;SP>;1<;/SP>;) - 4 - diethylaminobutanone - 2. Similarly using #-naphthol in place of cresol the corresponding #-naphthoxy compound is obtained. (3) Guaiacoxy-acetone from guaiacol and monochloracetone is reacted with the crude condensation product of formaldehyde and piperidine to give 1-(2<;SP>;1<;/SP>;-methoxyphenoxy-1<;SP>;1<;/SP>;)-4- piperidyl-butanone 2. (4) The condensation product of morpholine and formaldehyde is reacted with methoxyphenoxy-acetone to give 1 - (21 - methoxyphenoxy - 1<;SP>;1<;/SP>;) - 4 - morpholinyl - butanone-2. (5) o-Benzyloxyphenoxy acetone prepared by treating pyro-catechine mono-benzyl ether with monochloracetone in the presence of sodium hydroxide is added to a cold mixture of piperidine, formaldehyde, benzene and sodium chloride to give 1-(21-benzyloxyphenoxy)-4-piperidyl-butanone-2. The free amino phenol may be obtained by acid hydrolysis. (6) Benzyloxyphenoxy acetone is added to the reaction mixture of methylcyclohexylamine and formaldehyde and worked up as in example (5) to give 1-(2'-benzyloxyphenoxy) - 4 - (methylcyclohexylamino) - butanone-2. The free amino-phenol is obtained by acid hydrolysis. (7) o-Benzyloxyphenoxyacetone prepared as in example (5) are added to a benzene solution of morpholine, formaldehyde and sodium chloride to give 1-(21- benzyloxyphenoxy-1<;SP>;1<;/SP>;)-4-morpholinyl-butanone- 2. The amino ketone is reduced by sodium in alcohol to form 1-(2<;SP>;1<;/SP>;-hydroxyphenoxy- 1<;SP>;1<;/SP>;)-4-morpholinyl-butanone-2. (8) Phenoxyacetone in benzene solution is added to morpholine and formaldehyde to form 1- phenoxy-4-morpholinyl-butanone-2. The corresponding 1 - phenoxy - 4 - morpholinyl - butanol-2 is obtained by reduction of the ketone by sodium in alcohol.

  552,454. 乙氧基-烷基氨基丁酮。GEIGY AKT.-GES.，J.R. 1941年10月7日，第12937号专利。公约日期，1940年10月8日。[第2类（iii）] 乙氧基-烷基氨基丁酮首先通过将一价酚或仅含有一个羟基的多价酚衍生物与一卤代丙酮缩合，然后用羟甲基胺处理生成的乙氧基丙酮来制备。在羟甲基胺的位置上，也可以使用由甲醛和一级或二级胺得到的反应混合物。所得的丁酮可以还原为相应的丁醇。在示例中（1）单氯代丙酮与邻甲酚在氢氧化钠存在下缩合，然后用通过对哌啶与甲醛反应得到的粗缩合产物处理所产生的邻甲氧基丙酮。通过蒸馏纯化得到的邻甲氧基丁酰基哌啶1-(2'-甲基苯氧-1')-4-哌啶基-丁酮-2。 （2）邻甲氧基丙酮的苯溶液与二乙胺反应生成1-(2'-甲基苯氧-1')-4-二乙基氨基丁酮-2。类似地，使用α-萘酚代替甲酚可得到相应的α-萘氧化合物。 （3）从愈创木酚和单氯代丙酮得到的愈创氧基丙酮与甲醛和哌啶的粗缩合产物反应，得到1-(2'-甲氧苯氧-1')-4-哌啶基-丁酮2。 （4）吗啉和甲醛的缩合产物与甲氧苯氧基丙酮反应，得到1-(2'-甲氧苯氧-1')-4-吗啉基-丁酮-2。 （5）通过将苯并二苯基醚与单氯代丙酮在氢氧化钠存在下反应制备的邻苯氧基丙酮添加到哌啶、甲醛、苯和氯化钠的冷混合物中，得到1-(2'-苯氧苯氧)-4-哌啶基-丁酮-2。通过酸水解可以得到游离氨基酚。 （6）苯氧基丙酮添加到甲基环己胺和甲醛的反应混合物中，并按照示例（5）的方法处理，得到1-(2'-苯氧苯氧)-4-(甲基环己基氨基)-丁酮-2。通过酸水解可以得到游离氨基酚。 （7）如示例（5）中制备的邻苯氧基丙酮添加到吗啉、甲醛和氯化钠的苯溶液中，得到1-(2'-苯氧苯氧-1')-4-吗啉基-丁酮-2。氨基酮通过酒精中的钠还原形成1-(2'-羟基苯氧-1')-4-吗啉基-丁酮-2。 （8）苯氧基丙酮在苯中加入吗啉和甲醛，形成1-苯氧基-4-吗啉基-丁酮-2。通过酒精中的钠还原酮可以得到相应的1-苯氧基-4-吗啉基-丁醇-2。
• Iridium-catalyzed enantioselective intramolecular hydroarylation of allylic aryl ethers devoid of a directing group on the aryl group
  作者：Toshimichi Ohmura、Satoshi Kusaka、Michinori Suginome

  DOI：10.1039/d1cc05684k

  日期：——

  Although intramolecular hydroarylation is an attractive transformation of allylic aryl ethers, it has suffered from narrow substrate scope. We herein describe Ir/(S)-DTBM-SEGPHOS-catalyzed intramolecular hydroarylation of allylic aryl ethers. The reaction eliminates the structural requirement from the aryl group, affording 2,3-dihydrobenzofurans bearing a stereogenic carbon center at the C3 position

  尽管分子内加氢芳基化是烯丙基芳基醚的一种有吸引力的转化，但它的底物范围狭窄。我们在此描述了 Ir/( S )-DTBM-SEGPHOS 催化的烯丙基芳基醚的分子内加氢芳基化。该反应消除了芳基的结构要求，提供了在 C3 位置带有立体碳中心的 2,3-二氢苯并呋喃，对映体过量高达 99%。
• 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS
  申请人：Janssen Pharmaceutica NV

  公开号：US20160199342A1

  公开（公告）日：2016-07-14

  The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

  这项发明涉及4-((苯氧烷基)硫基)-苯氧乙酸及其类似物、包含它们的组合物，以及使用它们作为PPARδ调节剂的方法，用于治疗或抑制例如脂质代谢异常等疾病的进展。
• 4-((PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS
  申请人：Kuo Gee-Hong

  公开号：US20110294875A1

  公开（公告）日：2011-12-01

  The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

  本发明涉及4-((苯氧烷基)硫基)-苯氧乙酸及其类似物，包含其的组合物，以及将其用作PPAR delta调节剂的方法，用于治疗或抑制例如脂质代谢异常等疾病的进展。